基因治疗方法的进步针对神经退行性疾病中的神经炎症
Kuldeep Singh1, Pranshul Sethi2, Samaresh Datta3
1Department of Pharmacology, Institue of Pharmaceutical Research, GLA University, Mathura, Uttar Pradesh, India.
Ageing research reviews
|May 9, 2024
概括
基因疗法提供了一种有前途的方法来对抗神经退行性疾病 (NDs) 中的神经炎症. 本综述探讨了先进的基因疗法策略,针对关键途径来保护神经元并改善阿尔茨海默氏症等疾病中的大脑功能.
科学领域:
- 神经科学是一个神经科学.
- 免疫学 免疫学 免疫学
- 遗传学 遗传学 是一个
背景情况:
- 神经退行性疾病 (NDs) 影响全球15%的人口,导致显著的认知和身体障碍.
- 神经炎症是各种ND的常见因素,包括阿尔茨海默病 (AD),帕金森病和ALS.
- 涉及NFκB等基因和TNF-α和IL-1β等细胞因子的炎症途径有助于NDs中的神经元损伤.
研究的目的:
- 审查最近在基因治疗策略中取得的进展,以调节神经退行性疾病中的神经炎症.
- 讨论神经炎症背后的分子机制,并确定关键的基因和相关蛋白质.
- 评估对ND的基因治疗的临床前和临床研究,并应对未来的挑战.
主要方法:
- 对针对神经炎症的基因疗法方法的综合文献综述.
- 分析分子通路和与神经炎症相关的遗传因素.
- 评估临床前和临床试验数据,以确定基因疗法在非临床试验中的疗效.
主要成果:
- 基因疗法显示出调节大脑炎症反应的潜力.
- 针对特定的基因和途径可以减少促炎性细胞因子的产生.
- 新兴的基因治疗策略在临床前的NDs模型中提供神经保护性益处.
结论:
- 基因疗法通过解决神经炎症,为神经退行性疾病提供了一个有前途的治疗途径.
- 需要进一步的研究和临床试验,以克服将基因疗法转化为有效治疗的挑战.
- 通过基因疗法调节神经炎症可能为NDS患者提供疾病修饰的好处.
更多相关视频
09:19High Throughput Characterization of Adult Stem Cells Engineered for Delivery of Therapeutic Factors for Neuroprotective Strategies
Published on: January 4, 2015
10.9K
06:48Limbal Approach-Subretinal Injection of Viral Vectors for Gene Therapy in Mice Retinal Pigment Epithelium
Published on: August 7, 2015
21.2K
相关概念视频
Gene Therapy
25.4K
Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be...
25.4K
Parkinson's Disease: Overview
533
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
533
